申请人:Pfizer Inc
公开号:US05422354A1
公开(公告)日:1995-06-06
Quinuclidine derivatives of the formula ##STR1## and the pharmaceutically acceptable salts thereof, wherein m, P, Z, Y, R.sup.1, R.sup.2 and R.sup.3 are as defined below. The compounds are substance P antagonists and, therefore, are useful in treating gastrointestinal disorders, central nervous system disorders, inflammatory diseases, pain and migraine.
公式为##STR1##的喹胺衍生物及其药用盐,其中m、P、Z、Y、R.sup.1、R.sup.2和R.sup.3的定义如下。这些化合物是P物质拮抗剂,因此可用于治疗胃肠道疾病、中枢神经系统疾病、炎症性疾病、疼痛和偏头痛。